PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK

PT Industri Jamu dan Farmasi Sido Muncul Tbk

SIDO

ID1000130305

Pharmaceuticals

End-of-day quote INDONESIA S.E. Other stock markets 2025-06-13			5-day change	1st Jan Change
505.00 ^IDR	-0.98%		-1.94%	-14.41%

May. 02	PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
Mar. 19	HSBC Upgrades Industri Jamu Dan Farmasi Sido Muncul to Buy from Hold; Price Target is 675 Rupiah	MT

PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2025

Published on 05/02/2025 at 17:03

PT Industri Jamu dan Farmasi Sido Muncul Tbk reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was IDR 789,105 million compared to IDR 1,053,423 million a year ago. Net income was IDR 232,940 million compared to IDR 390,493 million a year ago.

Basic earnings per share from continuing operations was IDR 7.77 compared to IDR 13.02 a year ago.

Latest news about PT Industri Jamu dan Farmasi Sido Muncul Tbk

PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2025	May. 02	CI
HSBC Upgrades Industri Jamu Dan Farmasi Sido Muncul to Buy from Hold; Price Target is 675 Rupiah	Mar. 19	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Full Year Ended December 31, 2024	Mar. 06	CI
Nomura Adjusts Industri Jamu Dan Farmasi Sido Muncul's Price Target to 700 Rupiah From 800 Rupiah, Keeps at Buy	Jan. 28	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Nine Months Ended September 30, 2024	24-10-24	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Half Year Ended June 30, 2024	24-07-24	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	24-04-25	CI
Nomura Adjusts Industri Jamu Dan Farmasi’s Price Target to IDR800 From IDR670, Keeps at Buy	24-04-18	MT
Hidayat family acquired 17.1% stake in PT Industri Jamu dan Farmasi Sido Muncul Tbk from Affinity Equity Partners Limited for approximately $200 million.	24-04-15	CI
Nomura Adjusts Industri Jamu Dan Farmasi Sido Muncul's Price Target to IDR670 From IDR750, Keeps at Buy	24-02-20	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	24-02-19	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Nomura Adjusts Industri Jamu Dan Farmasi Sido Muncul’s Price Target to 750 Rupiahs From 870 Rupiahs, Keeps at Buy	23-10-10	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-26	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-26	CI
Nomura Adjusts Industri Jamu dan Farmasi Sido Muncul's Price Target to IDR870 From IDR1,050, Keeps at Buy	23-07-13	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Nomura Adjusts PT Industri Jamu Dan Farmasi Sido Muncul's Price Target to IDR1,050 From IDR920, Keeps at Buy	23-03-30	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-10	CI
Nomura Adjusts Industri Jamu Dan Farmasi Sido Muncul's Price Target to IDR920 From IDR860, Keeps at Buy	23-01-30	MT
PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Nomura Upgrades Industri Jamu dan Farmasi to Buy From Neutral, Keeps Price Target at 860 Rupiahs	22-10-18	MT
UBS Downgrades Industri Jamu Dan Farmasi Sido Muncul to Sell From Buy, Adjusts Price Target to 650 Rupiahs From 1,200 Rupiahs	22-08-26	MT
Nomura Downgrades Industri Jamu dan Farmasi to Neutral From Buy, Adjusts Price Target to 860 Indonesian Rupiahs From 1,170 Rupiahs	22-08-02	MT

Chart PT Industri Jamu dan Farmasi Sido Muncul Tbk

Duration

Period

Chart PT Industri Jamu dan Farmasi Sido Muncul Tbk

SIDO: Dynamic Chart

Company Profile

PT Industri Jamu Dan Farmasi Sido Muncul Tbk is an Indonesia-based company, which carries out business activities in herbal industry, such as medical industry (pharmacy), herbs, cosmetics, foods and beverages related to health, commerce, land transportation, services, wastewater treatment, plantation, and printing. The Company's segments include Herbal medicine and supplement, Food and beverages, and Pharmacy. The Companyâs products include Tolak Angin Cair, Tolak Angin Anak + Madu, Tolak Angin Flu, Tolak Angin Sugar Free, Sido Muncul Tolak Linu, Kuku Bima Ener-G!, Susu Jahe, Kopi Jahe, Sido Muncul C-1000 (Dengan Ekstrak Lemon), Esemag, Sari Kunyit Soft Capsule, Tolak Angin Soft Capsule, Tolak Linu Soft Capsule, JSH Capsule, VCO Soft Capsule, Sido Muncul Vitamin D3 400 IU, Sido Muncul VItamin E 100 IU, Sido Muncul Vitamin E 300 IU, Minuman Madu dengan Jahe maduSido, Tolak Angin Care, Tolak Linu Cool, Anak Sehat Rasa Anggur, Anak Sehat Rasa Coklat, and Anak Sehat Rasa Jambu Merah.

Employees

3,602

Sector

Pharmaceuticals

Calendar

Jul. 28 - Q2 2025 Earnings Release (Projected)

More about the company